PWMS News Search Results

Back to NewsWire Home
Back to
  Back to PeopleWithMS NewsWire 

April 2008 Off the Wire . . .




Novartis branded Betaseron approved in Europe as Extavia

Submitted by art on Mon, 2008-04-07 06:49

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending to grant a marketing authorisation for the medicinal product Extavia, which is Betaseron (called Betaferon in Europe) sold via Novartis via an agreement with Bayer.

Not earth-shattering news, but useful to know what name they use so you understand it when you hear it.

E-Mail the NewsWire e-mail the NewsWire ! ! ! - Handpainted and Customized Canes
 with any news items you discover 

copyright 2003